PubRank

A Liso

Author PubWeight™ 23.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia 2005 1.67
2 Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia 2009 1.56
3 Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study. Blood 1999 1.40
4 Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 2007 1.36
5 Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood 1997 1.12
6 Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 1996 1.11
7 Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation. Bone Marrow Transplant 2006 1.01
8 In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. Leukemia 2007 0.98
9 Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. Leukemia 2007 0.98
10 FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Ann Hematol 2003 0.96
11 Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol 1997 0.91
12 Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. Leukemia 2006 0.90
13 CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. Histopathology 1997 0.90
14 FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia. Ann Hematol 2005 0.86
15 Detection of CD4 T-cell responses to a tumor vaccine by cytokine flow cytometry. Clin Cancer Res 2001 0.84
16 Preliminary evidence for high anti-PLAC1 antibody levels in infertile patients with repeated unexplained implantation failure. Placenta 2013 0.83
17 Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplant 2004 0.81
18 The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention. Curr Drug Targets Immune Endocr Metabol Disord 2004 0.80
19 Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors. Curr Drug Targets Immune Endocr Metabol Disord 2004 0.80
20 NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia 2008 0.80
21 A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. Leukemia 2008 0.79
22 Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. Leukemia 2007 0.78
23 Fungemia in acute leukemia patients: a single institution's experience. New Microbiol 2004 0.77
24 Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases. Ann Hematol 2004 0.76
25 Endovascular treatment of carotid atherosclerotic disease: early and late outcome in a non-selected population. Ital Heart J 2000 0.75
26 Targeted antibodies in the treatment of lymphomas. Cancer Surv 1997 0.75